People from Culturally and Linguistically Diverse (CALD) backgrounds are significantly under-represented in Australian clinical trials. Language and translation difficulties, cultural beliefs about health, medicine and research, and a lack of existing relationships between health and medical researchers and CALD communities, are just some of the barriers.
The Australian Clinical Trials Alliance (ACTA) has released a set of recommendations aimed at advancing clinical trial engagement, involvement, and participation for people from CALD backgrounds.
- Community led engagement and involvement,
- Embedding learning and building capability to support sustainable CALD inclusion, and
- Strengthening a National Clinical Trial System to promote inclusion for CALD people.
These recommendations have been submitted to the Department of Health as part of the efforts to promote cultural diversity in clinical trials.
Monash Partners’ supports ACTA’s commitment to reflect the diversity of our society and cultures in the selection of clinical research participants and are pleased to present, in partnership with Sydney Health Partners, the following webinar:
REACHING OUT: involving under-represented populations in clinical trials
Date: Tuesday 20 June, 11.30am to 1pm AEST online
Focus: involving people from CALD communities in clinical trials – both as partners and participants.
We look forward to seeing you there!
Additionally, I would like to congratulate the recipients of the newly launched Monash Partners Strategic Translation and Research (MP STAR) Clinician Fellow Program. Read more here.